Presentation is loading. Please wait.

Presentation is loading. Please wait.

Elizabeth A. David, MD, David T

Published byMartina Hood Modified over 5 years ago

Similar presentations

Presentation on theme: "Elizabeth A. David, MD, David T"— Presentation transcript:

1 Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? 
Elizabeth A. David, MD, David T. Cooke, MD, Yingjia Chen, MPH, Kieranjeet Nijar, BS, MS, Robert J. Canter, MD, MAS, Rosemary D. Cress, DrPH  The Annals of Thoracic Surgery  Volume 103, Issue 1, Pages (January 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Distribution of number of lymph nodes sampled.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Number of lymph nodes sampled by type of resection: sublobar resection (solid bars), lobectomy (shaded bars), and pneumonectomy (open bars). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Cause-specific survival Kaplan-Meier curves (log rank test, p < ) for (A) entire cohort, (B) stage I, (C) stage II, and (D) stage III. Number of lymph nodes removed: 0 (blue lines); 1 to 3 (red lines); 4 to 10 (green lines); and 10 or more (yellow lines). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Overall survival Kaplan-Meier curves (log rank test, p < ) for (A) entire cohort, (B) stage I, (C) stage II, and (D) stage III. Number of lymph nodes removed: 0 (blue lines); 1 to 3 (red lines); 4 to 10 (green lines); and 10 or more (yellow lines). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Elizabeth A. David, MD, David T"

Similar presentations

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Chun Chieh Lin, PhD, MBA, Matthew P

Chun Chieh Lin, PhD, MBA, Matthew P
Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer  Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.

Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer  Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Ravi Rajaram, MD, MSc, Jennifer L

Ravi Rajaram, MD, MSc, Jennifer L
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Similar presentations

Ads by Google